// App-Quantinova.ai

1313 : Severe Infections in Patients with Chronic Lymphocytic Leukemia Treated with (Immuno-)Chemotherapy: A Pooled Analysis of Gcllsg Trials

Researchers

Presenter

  • Othman Al-Sawaf

Principal Investigators

  • Sandra Robrecht

  • Anna-Maria Fink

  • Paula Cramer

  • Carmen D. Herling

  • Julia Von Tresckow

  • Elisabeth Lange

  • Sebastian Bttcher

  • Michael G. Kiehl

  • Martin Dreyling

  • Ulrich Jaeger

  • Michael Gregor

  • Ursula Vehling-Kaiser

  • Matthias Ritgen

  • Jan Drig

  • Eugen Tausch

  • Stephan Stilgenbauer

  • Clemens-Martin Wendtner

  • Kirsten Fischer

  • Valentin Goede

  • Michael Hallek

  • Barbara Eichhorst

  • Petra Langerbeins

Medical Centers

  • University Hospital Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, Cologne, Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Cologne-Bonn, German CLL Study Group, University of Cologne, Cologne, Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

  • University Hospital Cologne, Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf; Cologne, Cologne, Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Düsseldorf, German Hodgkin Study Group, Faculty of Medicine and University Hospital of Cologne,University Hospital of Cologne,Cologne,Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

  • Department of Hematology and Oncology, Evangelisches Krankenhaus Hamm, Hamm, Germany

  • Department of Internal Medicine III ,

  • Department of Internal Medicine, Klinikum Frankfurt (Oder) GmbH, Frankfurt, Germany

  • Department of Internal Medicine III, University Hospital Grohadern, Ludwig-Maximilians-Universitat Munchen, Munich, Germany

  • Department of Internal Medicine II / Medical University of Vienna, Vienna, Wien, Austria

  • Division of Hematology, Cantonal Hospital of Lucerne, Lucerne, Switzerland

  • Hematology Oncology, Dayclinic Landshut, Landshut, Germany

  • Department of General Pediatrics, University Hospital Schleswig-Holstein, Kiel, Germany

  • Department of Ophthalmology, Essen University Hospital, Essen, Germany

  • Department of Internal Medicine, University Hospital of Ulm, Ulm, Germany

  • Internal Medicine I, Saarland University Medical School, Homburg, Germany

  • Department of Hematology, Oncology, Immunology, Palliative Care, Infectious Diseases and Tropical Medicine, Klinikum Schwabing, Munich, Germany

  • Department of Geriatric Medicine, St. Marien Hospital, Cologne, Germany

  • Department I of Internal Medicine and Center of Integrated Oncology Aachen, Bonn, Cologne, Duesseldorf, University of Cologne, Cologne, Germany

Locations

  • Germany

  • Austria

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Chronic Lymphocytic Leukemia

Biomarkers

  • Circulating tumor cells

Drug/Treatment

  • Cyclophosphamide

  • Cyclophosphamide Injection

  • Obinutuzumab

  • Obinutuzumab Intravenous

  • Bendamustine

  • chlorambucil

  • fludarabine tablet

  • Rituximab

Outcome

  • N/A

Study Design

  • N/A

Phase

  • II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved